FDA.reportPublic FDA data

NDC 63672-0044-3 - Amlodipine Besylate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63672-0044
Requested NDC
63672-0044-3
Package NDCs from labels
63672-0044-3
Manufacturer
Synthon Pharmaceuticals, Inc.
Effective date
2008-01-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Amlodipine Besylate TabletsSynthon Pharmaceuticals, Inc.2008-01-23HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63672-0044-3Amlodipine Besylate90 in 1 BOTTLETABLET901

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63672-0044AMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]11 package rows20080130_6E9A6C82-9F25-4C71-B09A-929BD5D7B1CF.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63672-0044-3EA - Each63672-004450b13dd6-34bc-4a84-9ecf-c5b53b40abf912015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Amlodipine besylateACTIVE INGREDIENT864V2Q084HAMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]1
AmlodipineACTIVE MOIETY1J444QC288AMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]1
magnesium stearateINACTIVE INGREDIENT70097M6I30AMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]1
microcrystalline celluloseINACTIVE INGREDIENTAMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]1
sodium starch glycolateINACTIVE INGREDIENTAMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET [SYNTHON PHARMACEUTICALS, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 7 · 124 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AMLODIPINE BESYLATEAMLODIPINE BESYLATEQuallent Pharmaceuticals Health LLCc262dedb-1d13-4447-9355-f11e1dbbfb4d2025-10-13Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEBryant Ranch Prepack6cf5ece4-4d4e-478e-be8f-bd198c6edc5d2025-09-29Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEAphena Pharma Solutions - Tennessee, LLC3ce6978a-6ab3-33a9-e063-6294a90a24a12025-08-21Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEDirect_Rx0c7d1f99-dfe0-7041-e063-6294a90a97052025-07-11Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATENuCare Pharmaceuticals,Inc.2437a130-d544-6db4-e063-6394a90a0d4d2025-06-13Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEA-S Medication Solutions921096ab-589a-4821-8d91-a6319f4a559a2025-04-09Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEA-S Medication Solutionsdc2107cd-edfa-44a6-b139-edee6ccf47ce2025-04-08Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEA-S Medication Solutions00a037f6-b17f-4d21-9a9a-0e682f68d4832025-04-02Warnings, Adverse reactionsExact identifier
rxcui: 308136
Amlodipine BesylateAMLODIPINE BESYLATEAphena Pharma Solutions - Tennessee, LLC313fe7ba-2fbd-bb4d-e063-6294a90a37492025-03-26Warnings, Adverse reactionsExact identifier
rxcui: 197361
AMLODIPINE BESYLATE 2.5 mgAMLODIPINE BESYLATEProficient Rx LP6313edc5-d2d5-44a1-a06f-7f7829c870d22025-02-01Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATERedpharm Drugfc61eee9-ee15-9078-e053-6394a90a22f42025-01-23Warnings, Adverse reactionsExact identifier
rxcui: 197361
AMLODIPINE BESYLATEAMLODIPINE BESYLATEDIRECT RXb8b9a3cd-c4e7-dfeb-e053-2a95a90aa7192025-01-17Warnings, Adverse reactionsExact identifier
rxcui: 308136
Amlodipine BesylateAMLODIPINE BESYLATENCS HealthCare of KY, LLC dba Vangard Labs47f228e9-4a34-4d14-988d-b06af90124b92025-01-16Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
AMLODIPINE BESYLATE 10 mgAMLODIPINE BESYLATEAphena Pharma Solutions - Tennessee, LLC1871ddaf-ed2c-c3ce-e063-6394a90a1bee2024-12-20Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEQuality Care Products, LLCa75e4797-6b7f-4366-9105-79d6877adac52024-12-19Warnings, Adverse reactionsExact identifier
rxcui: 197361
Amlodipine BesylateAMLODIPINE BESYLATEQuality Care Products, LLC6b7c18ef-3a85-4ae3-9135-7ac30a0dde082024-12-17Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308135
amlodipine besylateAMLODIPINE BESYLATEMylan Pharmaceuticals Inc.180ee374-24f2-4b9c-9d54-8815f2b1dc9b2024-11-28Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEZydus Lifesciences Limitedcacb3551-c579-41cb-bed6-4b4d8b0644fc2024-11-25Exact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEProficient Rx LPf18148f9-42b2-43dc-9cf8-212d9121dc5f2024-11-01Warnings, Adverse reactionsExact identifier
rxcui: 308135
Amlodipine BesylateAMLODIPINE BESYLATEZydus Pharmaceuticals USA Inc.fda0739d-b355-478c-acae-8f773a3ec4b32024-10-18Warnings, Adverse reactionsExact identifier
rxcui: 197361
rxcui: 308136
rxcui: 308135

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.